The University of Texas at San Antonio (UTSA) and GenCure are working together on the development of cellular therapy products and services under a new master services agreement. GenCure will provide UTSA with research starting materials, and UTSA will offer testing services for materials produced by GenCure. The collaboration aims to boost the clinical application of stem cell therapeutics.
SpyCloud Research Shows that Endpoint Detection and Antivirus Solutions Miss Two-Thirds (66%) of Malware Infections
SpyCloud, an identity threat protection company, has found that 66% of malware infections bypass endpoint protection solutions, regardless of their advanced artificial intelligence and telemetry
